Skip to main content

Part of the book series: Developments in Nephrology ((DINE,volume 1))

  • 78 Accesses

Abstract

The kidneys play an important role in the pathophysiology of hypertension. In patients with a variety of renal diseases, impaired sodium excretion as well as disturbances in renal vasoactive hormone metabolism may be the stimuli which raise blood pressure (Table 1). It should be recognized that there is no meaningful dividing line between ‘hypertension’ and ‘normotension’. Blood pressure is a quantity, and the risks of organ damage seem to be a direct function of the arterial pressure. Our practice is to regard the patient with a diastolic blood pressure persistently over 95 mm Hg as a candidate for antihypertensive therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 349.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bachy C, Alexandre GPJ, van Ypersele de Strihou C: Hypertension after renal transplantation. Br Med J 2: 1287–1289, 1976.

    Article  PubMed  CAS  Google Scholar 

  2. Bank N, Lief PD, Piczon O: Use of diuretics in treatment of hypertension secondary to renal disease. Arch Int Med 138: 1524–1529, 1978.

    Article  CAS  Google Scholar 

  3. Bennett WM, McDonald WJ, Hartnett MN, et al: Do diuretics have antihypertensive properties independent of natriuresis? Clin Pharmacol Exp Ther 22: 499–504, 1977.

    CAS  Google Scholar 

  4. Bennett WM, McDonald WJ, Lawson RK, Porter GA: Post-transplant hypertension: studies of cortical blood flow and the renal pressor system. Kidney Int 6: 99–108, 1974.

    Article  PubMed  CAS  Google Scholar 

  5. Bennett WM, Porter GA: Efficacy and safety of metolazone in renal failure and the nephrotic syndrome. J Clin Pharmacol 13: 357–364, 1973.

    PubMed  CAS  Google Scholar 

  6. Beretta-Piccoli C, Weidmann P, DeChatel R, Reubi F: Hypertension associated with early stage kidney disease. Complementary roles of circulating renin, the body sodium/volume state and duration of hypertension. Am J Med 61: 739–747, 1976.

    Article  PubMed  CAS  Google Scholar 

  7. Brown JJ, Gleadle RI, Lawson DH, et al: Renin and acute renal failure: studies in man. Br Med J 1: 253–258, 1970.

    Article  PubMed  Google Scholar 

  8. Cohen SL: Hypertension in renal transplant recipients: role of bilateral nephrectomy. Br Med J 3: 78–81, 1973.

    Article  PubMed  CAS  Google Scholar 

  9. Dathan JRE, Johnson DB, Goodwin FJ: The relationship between body fluid compartment volumes, renin activity, and blood pressure in chronic renal failure. Clin Sei Mol Med 45: 77–88, 1973.

    CAS  Google Scholar 

  10. David DS, Sakai S, Brennan BL, et al: Hypercalcemia after renal transplantation. New Engl J Med 289: 398–401, 1973.

    Article  PubMed  CAS  Google Scholar 

  11. DeFazio V, Christensen RC, Regan TJ, et al: Circulatory changes in acute glomerulonephritis. Circulation 20: 190–200, 1959.

    PubMed  CAS  Google Scholar 

  12. DelGreco F Davies WA, Simon NM, et al: Hypertension of chronic renal failure: role of sodium and the renal pressor system. Kidney Int 7:suppl 2 S176–S183, 1975.

    Google Scholar 

  13. Dustan HP, Tarazi RC, Bravo EL: Dependence of arterial pressure on intravascular volume in treated hypertensive patients. New Engl J Med 286: 861–866, 1972.

    Article  PubMed  CAS  Google Scholar 

  14. Franklin SS, Young JD Jr, Maxwell MH, et al: Operative morbidity and mortality in renovascular disease. JAMA 231: 1148–1153, 1975.

    Article  PubMed  CAS  Google Scholar 

  15. Frewin DB, Penhall RK: Rebound hypertension after sudden discontinuation of methyldopa therapy. Med J Austr 1: 659, 1977.

    CAS  Google Scholar 

  16. Hansson L, Hunyor SN, Julius S, et al: Blood pressure crisis following withdrawal of Clonidine (captapres, catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J 85: 605–610, 1973.

    Article  PubMed  CAS  Google Scholar 

  17. Harrison EG Jr, McCormack LJ: Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc 46: 161–167, 1971.

    PubMed  Google Scholar 

  18. Holland OB, Kaplan NM: Propranolol in the treatment of hypertension. New Engl J Med 294: 930–936, 1976.

    Article  PubMed  CAS  Google Scholar 

  19. Kim KE, Onesti G, Swartz CD: Hemodynamics of hypertension in uremia. Kidney Int 7:suppl 2: S155–S162, 1975.

    Google Scholar 

  20. Koch-Weser J: Hypertensive emergencies. New Engl J Med 290: 211–214, 1974.

    Article  PubMed  CAS  Google Scholar 

  21. Lacombe M: Arterial stenosis complicating renal allotransplantation in man: a study of 38 cases. Ann Surg 181: 283–288, 1975.

    Article  PubMed  CAS  Google Scholar 

  22. Laragh JE, Sealey JE, Buhler FR, et al: The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension: Am J Med 58: 4–13, 1975.

    Article  PubMed  CAS  Google Scholar 

  23. Lazarus JM, Hampers CL, Merrill JP: Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy. Arch Int Med 133: 1059–1066, 1974.

    Article  CAS  Google Scholar 

  24. Linas SL, Miller PD, McDonald KM, et al: Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys. New Engl J Med 298: 1440–1444, 1978.

    Article  PubMed  CAS  Google Scholar 

  25. Lyons H, Pinn VW, Cortell S, et al: Alergic interstitial nephritis causing reversible renal failure in four patients with idiopathic nephrotic syndrome. New Engl J Med 288: 124–128, 1973.

    Article  PubMed  CAS  Google Scholar 

  26. Maxwell MH, Luper AN, Kaufman JJ: Individual kidney function tests in renal arterial hypertension. J Urol 100: 384–394, 1968.

    PubMed  CAS  Google Scholar 

  27. Morgan DB, Ball SR, Thomas TH, Lee MR: Sodium losing renal disease: Two cases and a review of the literature. Quart J Med 47: 21–34, 1978.

    PubMed  CAS  Google Scholar 

  28. Morris PJ, Yadav RUS, Kinkaid-Smith P, et al: Renal artery stenosis in renal transplantation. Med J Austr 58: 1255–1257, 1971.

    Google Scholar 

  29. Pettinger WA, Mitchell HC: Minoxidil—an alternative to nephrectomy for refractory hypertension. New Engl J Med 289: 167–173, 1973.

    Article  PubMed  CAS  Google Scholar 

  30. Pillay VKG, Schwartz FD, Aimi K, Kark RM: Transient and permanent deafness following treatment with ethacrynic acid in renal failure. Lancet 1: 77–79, 1969.

    Article  PubMed  CAS  Google Scholar 

  31. Popovtzer MM, Pinneggera W, Katz FH, et al: Variations in arterial blood pressure after kidney transplantation. Relation to renal function, plasma renin activity, and the dose of prednisone. Circulation 47: 1297–1305, 1973.

    PubMed  CAS  Google Scholar 

  32. Rao TKS, Gupta SK, Butt KMH, et al: Relationship of renal transplantation to hypertension in end-stage renal failure. Arch Int Med 138: 1236–1241, 1978.

    Article  Google Scholar 

  33. Schalekamp MA, Beevers DG, Briggs JD, et al: Hypertension in chronic renal failure. An abnormal relation between sodium and the renin-angiotensin system. Am J Med 55: 379–390, 1973.

    Article  PubMed  CAS  Google Scholar 

  34. Simon N, Franklin SS, Bleifer KH, Maxwell MH: Clinical characteristics of renovascular hypertension. JAMA 220: 1209–1218, 1972.

    Article  PubMed  CAS  Google Scholar 

  35. Smellie WAB, Vinik M, Hume DM: Angiographic investigation of hypertension complicating human renal transplantation. Surg Gyn Obst 128: 963–968, 1969.

    PubMed  CAS  Google Scholar 

  36. Weidmann P, Baretta-Piccoli C, Hirsch D, et al: Curable hypertension with unilateral hydronephrosis. Studies on the role of circulating renin. Ann Int Med 87: 437–440, 1977.

    PubMed  CAS  Google Scholar 

  37. Wigend ME, Heidland A: Ototoxic side effects of high doses of frusemide in patients with uraemia. Postgr Med J 47:suppl 54, 1971.

    Google Scholar 

  38. Yeh BK, Dayton PG, Waters WC, III: Removal of alphamethyldopa (Al- domet) in man by dialysis. Proc Soc Exp Biol Med 135: 840–843, (1970).

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Martinus Nijhoff Publishers bv, The Hague

About this chapter

Cite this chapter

Leslie, B.R. (1981). Renal Hypertension. In: Cheigh, J.S., Stenzel, K.H., Rubin, A.L. (eds) Manual of Clinical Nephrology of the Rogosin Kidney Center. Developments in Nephrology, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8210-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-8210-9_12

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-8212-3

  • Online ISBN: 978-94-009-8210-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics